Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Insomnia-related comorbidities and economic costs among a commercially insured population in the United States
Current Medical Research and Opinion, 06/29/09
Pollack M et al. - Though identified patients were required to have enrollment in both medical and productivity databases, and the presence of insomnia could not be verified through medical records, these results suggest a significant link between insomnia and higher rates of comorbid conditions, healthcare expenditures and productivity losses. Payers and employers should consider insomnia as a factor in disease-related case-management initiatives.
Related Articles
Examining maladaptive beliefs about sleep across insomnia patient groups
Journal of Psychosomatic Research, 11/09/09
Relevance Score: 91%
Psychosocial job characteristics and insomnia: A prospective cohort study using the Demand-Control-Support (DCS) and Effort–Reward Imbalance (ERI) job stress models
Sleep Medicine, 11/18/09
Relevance Score: 89%
Does mental health history explain gender disparities in insomnia symptoms among young adults?
Sleep Medicine, 11/16/09
Relevance Score: 87%
Computer Based Synchronization Analysis on Sleep EEG in Insomnia
The Journal of Medical Systems, 10/26/09
Relevance Score: 87%
Singular Spectrum Analysis of Sleep EEG in Insomnia
The Journal of Medical Systems, 10/08/09
Relevance Score: 87%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Kinematic improvement following Botulinum Toxin-A injection in upper limb spasticity due to stroke
Journal of Neurology, Neurosurgery, and Psychiatry , 12/07/09
Effects of Methylphenidate on Cerebral Glucose Metabolism in Patients With Impaired Consciousness After Acquired Brain Injury
Clinical Neuropharmacology, 12/07/09
Gabapentin Enacarbil in Restless Legs Syndrome: A Phase 2b, 2-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Clinical Neuropharmacology, 12/07/09
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Costs and benefits of dropout schedules of test-restudy practice: Implications for student learning
Applied Cognitive Psychology, 12/07/09
Early and Late Direct Costs in a Southern African Antiretroviral Treatment Programme: A Retrospective Cohort Analysis
PLoS Medicine, 12/04/09
Economic Evaluation of Pharmacotherapy of Migraine Pain: A Review of the Literature
Journal Of Pain & Palliative Care Pharmacotherapy, 12/02/09
Sponsor
Article Search
Sponsor


See Latest Articles


